tofacitinib,infliximab,ustekinumab,vedolizumab,golimumab,adalimumab
janssen,pfizer,abbvie,takeda
['octave', 'crohn', 'tofa', 'unifi ', 'ulcerative colitis', 'ibd']
ibd is evolving rapidly! but the pivotal trials are so important to be aware of! catch up on them if new or old to ibd. it is still relevant! great talk at aibd app breakout session!! #aibd2022 